Michael Gordon Selected Research

phentolamine drug combination papaverine

11/2005

Erectile dysfunction in spinal cord injury: a cost-utility analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Gordon Research Topics

Disease

26	Neoplasms (Cancer) 01/2021 - 03/2004
8	Colorectal Neoplasms (Colorectal Cancer) 10/2008 - 05/2005
7	Opioid-Related Disorders (Opiate Addiction) 01/2018 - 03/2015
5	Renal Cell Carcinoma (Grawitz Tumor) 12/2020 - 11/2007
5	Fatigue 12/2020 - 12/2017
4	Disease Progression 01/2021 - 04/2008
4	Carcinoma (Carcinomatosis) 12/2020 - 04/2010
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 11/2013
3	Adenocarcinoma 11/2020 - 04/2008
3	Hypotension (Low Blood Pressure) 10/2020 - 09/2011
3	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 11/2017
3	Exanthema (Rash) 01/2018 - 01/2006
3	Pain (Aches) 07/2017 - 11/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2017
2	Myalgia 10/2020 - 11/2016
2	Dehydration (Water Stress) 10/2020 - 01/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 07/2014
2	Nausea 10/2020 - 11/2016
2	Myopia 05/2017 - 01/2016
2	Astigmatism 05/2017 - 01/2016
2	Cognitive Dysfunction 01/2013 - 05/2011
2	Alzheimer Disease (Alzheimer's Disease) 05/2011 - 01/2003
1	Melanoma (Melanoma, Malignant) 12/2020
1	Constipation 10/2020
1	Hyponatremia 10/2020
1	Alopecia (Baldness) 10/2020
1	Diarrhea 10/2020
1	Autoimmune Diseases of the Nervous System 10/2020
1	Uterine Neoplasms (Uterine Cancer) 01/2019
1	Otitis Media with Effusion 01/2019
1	Asthenia 01/2018
1	Hypokalemia 01/2018
1	Substance-Related Disorders (Drug Abuse) 01/2018
1	Dermatitis 01/2018
1	Depressive Disorder (Melancholia) 01/2018
1	Paronychia 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Dysgeusia (Parageusia) 12/2017

Drug/Important Bio-Agent (IBA)

6	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2005
6	Naltrexone (ReVia)FDA LinkGeneric 01/2018 - 03/2016
5	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2006
4	B7-H1 AntigenIBA 01/2021 - 01/2018
4	atezolizumabIBA 01/2021 - 01/2019
4	Monoclonal AntibodiesIBA 11/2020 - 01/2006
4	PlatinumIBA 01/2019 - 07/2005
4	Irinotecan (Camptosar)FDA LinkGeneric 10/2008 - 01/2006
3	Immunoglobulin G (IgG)IBA 12/2020 - 01/2006
3	Gemcitabine FDA Link 11/2020 - 04/2008
3	Pharmaceutical PreparationsIBA 01/2018 - 11/2005
3	Opioid Analgesics (Opioids)IBA 01/2018 - 03/2016
3	Cetuximab (Erbitux)FDA Link 08/2007 - 05/2005
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2013
2	GlucocorticoidsIBA 12/2020 - 01/2009
2	Immunoconjugates (Immunoconjugate)IBA 12/2020 - 01/2019
2	andecaliximabIBA 11/2020 - 01/2018
2	avelumabIBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 05/2005
2	Carboplatin (JM8)FDA LinkGeneric 12/2014 - 07/2014
2	Fluorouracil (Carac)FDA LinkGeneric 10/2008 - 01/2006
2	Cyclin D1IBA 07/2006 - 05/2005
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2006 - 07/2005
2	Interleukin-8 (Interleukin 8)IBA 07/2005 - 05/2005
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	avapritinibIBA 01/2021
1	dabrafenibIBA 12/2020
1	trametinibIBA 12/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020
1	durvalumabIBA 12/2020
1	Mitogen-Activated Protein KinasesIBA 12/2020
1	Immunoglobulins (Immunoglobulin)IBA 12/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2020
1	130-nm albumin-bound paclitaxelIBA 11/2020
1	ripretinibIBA 10/2020
1	epacadostatIBA 10/2020
1	Oncogene Proteins (Oncogene Protein)IBA 10/2020
1	Aligeron (AS 2)IBA 01/2020
1	A 7 (A-7)IBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	navicixizumabIBA 01/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019
1	navoximodIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	Therapeutic UsesIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 12/2017

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2002
9	Drug Therapy (Chemotherapy) 11/2020 - 07/2005
3	Laser In Situ Keratomileusis (LASIK) 05/2017 - 01/2015
3	Injections 03/2016 - 11/2005
2	Castration 01/2021 - 11/2017
2	Secondary Prevention 03/2015 - 05/2011
2	Conduction Anesthesia (Regional Anesthesia) 11/2011 - 09/2011
1	Immunotherapy 01/2020
1	Intravenous Infusions 01/2018
1	Thermometers 01/2018